FDA is “Deeply Concerned” About Vaginal Rejuvenation Risks

Image for post
Image for post

Multiple companies have been deceptively marketing medical devices for unapproved vaginal rejuvenation procedures, and as treatments for symptoms of menopause, urinary incontinence or sexual dysfunction.

Last week, the U.S. Food and Drug Administration issued a statement to inform the public that these devices, which are intended to use laser and radiofrequency for other indications, are being unsafely marketed for unapproved uses.

  • Alma Lasers | FemiLift
  • BTL Industries | Exilis Ultra Femme 360
  • Cynosure | MonaLisa Touch
  • InMode | Votiva FormaV and FractoraV
  • Sciton | JOULE Multi-Platform System
  • Thermigen | THERMIva
  • Venus Concept | Venus Fiore System

“These products have serious risks and don’t have adequate evidence to support their use for these purposes,” Scott Gottlieb, M.D. and FDA commissioner, wrote in the statement. “We are deeply concerned women are being harmed.”

Off-label marketing is a widespread issue in the medical field. No energy-based vaginal rejuvenation devices are currently approved by the agency, and women who have these procedures may experience side effects.

MonaLisa Touch Vaginal Rejuvenation Marketing
MonaLisa Touch Vaginal Rejuvenation Marketing
Source: Euphoria Wellness Spa

In the statement published on July 30, the FDA identified seven companies advertising approved medical devices for unapproved indications, such as:

  • Vaginal laxity
  • Vaginal atrophy, dryness, or itching
  • Pain during sexual intercourse
  • Pain during urination
  • Decreased sexual sensation

Energy-based laser and radiofrequency devices are legally used to treat certain gynecologic issues by destroying or reshaping tissue in the body. The devices are approved for abnormal, pre-cancerous tissue in the vagina or cervix. They’re also used to treat genital warts.

MonaLisa Touch Vaginal Rejuvenation Marketing
MonaLisa Touch Vaginal Rejuvenation Marketing
Source: Womens’ Center for Integrative Health

The FDA statement indicated that both doctors and patients are being prompted to use these devices for sexual health issues, such as discomfort and vaginal dryness. In a promotional video for Cynosure’s MonaLisa Touch, laser-based vaginal rejuvenation is described as “new” and “easy” with no anesthesia and minimal side effects.

Manufacturers are even promoting vaginal rejuvenation treatments for breast cancer survivors who may be experiencing early menopause, according to the FDA statement.

“The deceptive marketing of a dangerous procedure with no proven benefit, including to women who’ve been treated for cancer, is egregious,” the FDA wrote in the statement.

Gottlieb has sent individual letters to the seven manufacturers, requesting a response within 30 days and making it clear that potential enforcement actions may be taken if the companies fail to comply.

The FDA urges doctors and patients to understand that safety and effectiveness of energy-based devices to perform vaginal rejuvenation has not been established, and many of these procedures can cause side effects.

The agency has reviewed the adverse event reports and discovered numerous complications, such as:

  • Vaginal burns
  • Scarring
  • Pain during sexual intercourse
  • Recurring or chronic pain

“We haven’t reviewed or approved these devices for use in such procedures,” according to the statement. “Thus, the full extent of the risks is unknown. But these reports indicate these procedures can cause serious harm.”

Additionally, in Sept. 2007, the American College of Obstetricians and Gynecologists issued an opinion on vaginal rejuvenation, claiming that “it is deceptive” to give the impression that these procedures are standard, and they may end up further traumatizing patients with unproven surgical procedures.

“It is deceptive to give the impression that vaginal rejuvenation, designer vaginoplasty, revirgination, G-spot amplification, or any such procedures are accepted and routine surgical practices. Absence of data supporting the safety and efficacy of these procedures makes their recommendation untenable. Patients who are anxious or insecure about their genital appearance or sexual function may be further traumatized by undergoing an unproven surgical procedure with obvious risks. Women should be informed about the lack of data supporting the efficacy of these procedures and their potential complications, including infection, altered sensation, dyspareunia, adhesions, and scarring .”

- American College of Obstetricians and Gynecologists

Women should be aware of the potential risks of using energy-based devices for conditions related to menopause, incontinence or sexual health. For women who have received vaginal rejuvenation therapy with energy-based devices and experienced side effects, reports should be filed through the FDA MedWatch Program.

The potential farse of vaginal rejuvenation has hit the mainstream, with coverage from the Today Show, NY Times and Teen Vogue. When the FDA issues a statement, it has a powerful impact — indicating the agency should continue to monitor these claims to protect women nationwide.

Written by

MedTruth is a digital magazine reporting on health, safety and justice. Join the revolution today at https://medtruth.com/.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store